← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Mustang Bio, Inc.
Worcester, MA
$1,998,672
Total funding
1
Grants
Funding over time
peak $999.3K · FY2021–22$1M$750K$500K$250K$0
'21
'22
Funding mix
By agency
NIH$1,998,672 · 1
By mechanism
R44$1,998,672 · 1
Investigators at Mustang Bio, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
A Phase 1, Open Label, Multicenter Trial to Assess the Safety, Tolerability and Efficacy of MB-106 in Patients with Relapsed or Refractory CD20+ B-Cell NHL or CLL$999,336
R44 · FY2021 · CA
A Phase 1, Open Label, Multicenter Trial to Assess the Safety, Tolerability and Efficacy of MB-106 in Patients with Relapsed or Refractory CD20+ B-Cell NHL or CLL$999,336
R44 · FY2022 · CA